Adhera Therapeutics, Inc. – OTC:ATRX

Adhera Therapeutics stock price today

$0
Financial Health
0
1
2
3
4
5
6
7
8
9

Adhera Therapeutics stock price monthly change

-100.00%
month

Adhera Therapeutics stock price quarterly change

-100.00%
quarter

Adhera Therapeutics stock price yearly change

-100.00%
year

Adhera Therapeutics key metrics

Market Cap
2.27M
Enterprise value
2.48M
P/E
-0.47
EV/Sales
N/A
EV/EBITDA
4.06
Price/Sales
N/A
Price/Book
-0.05
PEG ratio
N/A
EPS
-0.51
Revenue
N/A
EBITDA
-1.73M
Income
-2.52M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Adhera Therapeutics stock price history

Adhera Therapeutics stock forecast

Adhera Therapeutics financial statements

Adhera Therapeutics, Inc. (OTC:ATRX): Profit margin
Dec 2022 0 1.62M
Mar 2023 0 -886K
Jun 2023 0 271K
Sep 2023 0 -3.53M
0%
Yield TTM
Adhera Therapeutics, Inc. (OTC:ATRX): Payout ratio
Payout ratio 0%
Adhera Therapeutics, Inc. (OTC:ATRX): Dividend Yield
2018 35.06%
2019 231.38%
2020 341.18%
2021 225.65%
2022
Adhera Therapeutics, Inc. (OTC:ATRX): Debt to assets
Dec 2022 79000 22.26M 28183.54%
Mar 2023 104000 23.19M 22304.81%
Jun 2023 82000 22.86M 27889.02%
Sep 2023 44074 26.35M 59807.4%
Adhera Therapeutics, Inc. (OTC:ATRX): Cash Flow
Dec 2022 -153K 0 52K
Mar 2023 -310K 0 347K
Jun 2023 -316K 0 305K
Sep 2023 -29.15K 0 3.78K

Adhera Therapeutics alternative data

Adhera Therapeutics, Inc. (OTC:ATRX): Employee count
Aug 2023 2
Sep 2023 2
Oct 2023 2
Nov 2023 2
Dec 2023 2
Jan 2024 2
Feb 2024 2
Mar 2024 2
Apr 2024 2
May 2024 2
Jun 2024 2
Jul 2024 2

Adhera Therapeutics other data

0.04% 0.00%
of ATRX is owned by hedge funds
1 +0
shares is hold by hedge funds

Adhera Therapeutics, Inc. (OTC:ATRX): Insider trades (number of shares)
Period Buy Sel
Apr 2018 2564627 0
Jul 2018 300040 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
MOSCATO ROBERT JR. director, officer: Chief Execut..
Series F Convertible Preferred Stock 40 $0.5 $20
Purchase
MOSCATO ROBERT JR. director, officer: Chief Execut..
Warrants to Purchase Common Stock 300,000 N/A N/A
Purchase
TRIEU VUONG director, 10 percent owner
Series E Convertible Preferred Stock 162 N/A N/A
Purchase
TRIEU VUONG director, 10 percent owner
Warrants to Purchase Common Stock 2,564,465 N/A N/A
Purchase
TRIEU VUONG director, 10 percent owner
Common Stock 10,000 $0.39 $3,900
Purchase
TRIEU VUONG director, 10 percent owner
Common Stock 20,000 $0.39 $7,800
Purchase
TRIEU VUONG director, 10 percent owner
Common Stock 2,500 $0.38 $950
Purchase
RAMELLI JOSEPH W. other: Former Chief Executive O..
Common Stock 22,500 $0.43 $9,563
Purchase
RAMELLI JOSEPH W. other: Former Chief Executive O..
Common Stock 13,000 $0.34 $4,368
Purchase
RAMELLI JOSEPH W. other: Former Chief Executive O..
Common Stock 97,550 $0.31 $30,436
  • What's the price of Adhera Therapeutics stock today?

    One share of Adhera Therapeutics stock can currently be purchased for approximately $0.

  • When is Adhera Therapeutics's next earnings date?

    Unfortunately, Adhera Therapeutics's (ATRX) next earnings date is currently unknown.

  • Does Adhera Therapeutics pay dividends?

    No, Adhera Therapeutics does not pay dividends.

  • How much money does Adhera Therapeutics make?

    Adhera Therapeutics has a market capitalization of 2.27M.

  • What is Adhera Therapeutics's stock symbol?

    Adhera Therapeutics, Inc. is traded on the OTC under the ticker symbol "ATRX".

  • What is Adhera Therapeutics's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Adhera Therapeutics?

    Shares of Adhera Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Adhera Therapeutics's key executives?

    Adhera Therapeutics's management team includes the following people:

    • Mr. Andrew Albert Kucharchuk Chief Executive Officer & Chairman(age: 44, pay: $124,140)
  • How many employees does Adhera Therapeutics have?

    As Jul 2024, Adhera Therapeutics employs 2 workers.

  • When Adhera Therapeutics went public?

    Adhera Therapeutics, Inc. is publicly traded company for more then 31 years since IPO on 15 Apr 1994.

  • What is Adhera Therapeutics's official website?

    The official website for Adhera Therapeutics is adherathera.com.

  • Where are Adhera Therapeutics's headquarters?

    Adhera Therapeutics is headquartered at PO Box 2161, Wake Forest, NC.

  • How can i contact Adhera Therapeutics?

    Adhera Therapeutics's mailing address is PO Box 2161, Wake Forest, NC and company can be reached via phone at +91 95183748.

Adhera Therapeutics company profile:

Adhera Therapeutics, Inc.

adherathera.com
Exchange:

OTC

Full time employees:

2

Industry:

Biotechnology

Sector:

Healthcare

Adhera Therapeutics, Inc. focuses on the discovery and development of drugs. The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018. Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana.

PO Box 2161
Wake Forest, NC 70820

CIK: 0000737207
ISIN: US00687E1091
CUSIP: 00687E109